Lexeo Therapeutics, Inc.
Q3 2025 13F Holders
Symbol
LXEO
CUSIP
52886X107
Type
Equity
Class
COM
Num filers
109
Total reported value, excl. options
$327M
Compare 2025 Q3 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Excl. options
Options only
All
Manager
Report Date
Value ($000)
Shares